India's Bharat Biotech says regulatory steps taken for Brazil vaccine contract
Brazil's health minister said on Tuesday the country will suspend its $324 million contract for 20 million doses of Bharat Biotech's vaccine after whistleblowers went public with alleged irregularities in the deal
Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called Covaxin, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi
India's Bharat Biotech said on Wednesday it followed a "step-by-step" approach for the regulatory approval and supply contract of its Covid-19 vaccine in Brazil, and that it has not received advance payments from the Brazilian health ministry.
Brazil's health minister said on Tuesday the country will suspend its $324 million contract for 20 million doses of Bharat Biotech's vaccine after whistleblowers went public with alleged irregularities in the deal.
Keep updated, follow The Business Standard's Google news channel
